Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion type Assertion NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_head.
- NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion wasGeneratedBy ECO_0000203 NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_provenance.
- NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion wasDerivedFrom befree-20140225 NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_provenance.
- NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion SIO_000772 15342390 NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_provenance.
- NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion evidence source_evidence_literature NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_provenance.
- NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_assertion description "[These results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216925.RAgB_bBYBkbRN_3he8Wk1-l2w15oISmmgKwkYpNK0cBe4130_provenance.